3.4 utility of pharmacogenomic testing for depression in adolescents: results from a prospective, double blind trial

The goal of this session is to evaluate the clinical impact of pharmacogenomic testing in clinical practice on treatment response/remission rates for depressed adolescent patients seeking pharmacologic treatment.
Source: Journal of the American Academy of Child and Adolescent Psychiatry - Category: Psychiatry Authors: Source Type: research